AGM/EGM Notice
Shree Ram Proteins Announces AGM E-Voting Cut-Off
Shree Ram Proteins fixed 5 December 2026 as the e-voting cut-off date for its 18th AGM scheduled on 12 December 2026.
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Bearish
2
Neutral
4
Bullish
8
Bearish
15
Neutral
21
Bullish
10
Bearish
13
Neutral
17
Bullish
2
Bearish
13
Neutral
17
Bullish
2
Bearish
13
Neutral
17
Bullish
2
Bearish
13
Neutral
17
Bullish
2
Investor Presentation
Q1 FY27
Investor Presentation
Q1 FY26
AGM/EGM Notice
Shree Ram Proteins fixed 5 December 2026 as the e-voting cut-off date for its 18th AGM scheduled on 12 December 2026.
AGM/EGM Notice
Shree Ram Proteins Limited will hold its 18th Annual General Meeting on December 12, 2026, at 2:30 p.m. through video conferencing, with remote e-voting available beforehand.
Shree Ram Proteins Ltd (SRPL) is currently trading at 0.34 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Shree Ram Proteins Limited is a Rajkot-based solvent-extraction and cottonseed processing company that manufactures cottonseed oil, de-oiled cake, linter and related cattlefeed products from a 400 MTPD processing facility; the company sells solvent products and operates a single reportable segment labelled “Solvent Products” in its filings. The company is in material financial distress: FY2025-26 audited results show a net loss of Rs. 1,010.85 lakhs, negligible operating revenue in FY2026, high finance and other expenses, and an adverse auditor opinion that highlights going-concern uncertainty and scope limitations on asset and inventory verification. Union Bank of India invoked remedies on loan default and auctioned the company’s plant and machinery on 18 May 2026 for Rs. 382.00 lakhs; the company previously accepted a one-time settlement (OTS) with upfront payments but missed subsequent instalments, creating continuing default and weakened asset base. Liquidity is critically constrained: cash and cash equivalents were Rs. 1.35 lakhs at year-end, significant short-term borrowings of approximately Rs. 2,011.57 lakhs, and management has stated it is raising additional funds while having withdrawn a previously proposed rights issue due to lack of investor interest.
Over the past 52 weeks, Shree Ram Proteins Ltd has traded between a low of ₹0.32 and a high of ₹0.70. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Shree Ram Proteins Ltd has a market capitalization of approximately 7.28. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Shree Ram Proteins Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -0.29 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 7.28 Cr, Shree Ram Proteins Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Shree Ram Proteins Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Shree Ram Proteins Ltd is -0.29. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Shree Ram Proteins’ reviewer said management had not prepared or documented an adequate going-concern assessment for the September 30, 2026 interim accounts. The reviewer also cited insufficient disclosure of the underlying conditions, mitigation plans and possible financial-statement effects. It therefore could not determine whether further adjustments or disclosures would have been required.
Shree Ram Proteins reported revenue from operations of ₹15.06 crore for the quarter ended September 30, 2026. This was lower than ₹16.46 crore reported in Q2 FY26, a decline of 8.5% year-on-year.
At its August 04, 2026 meeting, the board approved a proposal to sell, transfer, lease, dispose of or otherwise transfer the whole or substantially the whole undertaking, subject to shareholder and other approvals.
Paper, Forest & Jute Products
Paper & Paper Products
7 Cr
Low Risk
-0.29
13.05
—
—
0.70
0.32
Sales CAGR
Profit CAGR
ROE
ROCE
